Zhuhai Fornia Medical Equipment Co., Ltd. was established in May 2000. In 2003, the Funia Science and Technology Park was built on the Science and Technology Innovation Coast of Zhuhai National High tech Zone. Currently, the company has various production workshops designed and built in accordance with GMP regulations and standards, including purification workshops with levels of 100000, 10000, and 100. We have internationally advanced production equipment and testing instruments, with excellent technical equipment and complete testing methods, and our process technology has reached the advanced level of the same industry in China.

Xiamen Innodx was founded in August , 2013 , with a registered capital of 500 million yuan . It is a member of Yangshengtang Group. It is the wholly-owned subsidiary of Beijing Wantai Biological Pharmacy Enterprise Co . , Ltd . , and a high technology enterprise dedicating in chemiluminescence immunoassay IVD reagent research and development , manufacturing, and sales. In line with “ We follow the science, and concern about the health ” quality policy, the company transforms the bio-technical achievements into excellent product and service for the public.

Founded in Shenzhen in 2008, aiming to be a global leader in the healthcare industry, Lifotronic has emerged as a premium brand with sales and service network at home and abroad.

Shenzhen Lando Biomaterials Co.,Ltd. was founded in early 2010 by several PhDs from Tsinghua University in collaboration with the Tsinghua University Research Institute in Shenzhen. With a registered capital of 55.55 million yuan, it has received over 150 million yuan in venture capital and is committed to the research and industrialization of high-end biomedical materials in fields such as burn and trauma, dentistry, and orthopedics. The company has subsidiaries such as Shenzhen Qikang Medical Equipment Co., Ltd. (a national high-tech enterprise).

YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specializing in developing, manufacturing, and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers. In May of 2021, YHLO successfully launched IPO and was listed on Shanghai Stock Exchange (Stock code: 688575).